ABT 224

Drug Profile

ABT 224

Alternative Names: ABT-224; AU 224

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Class Gastrokinetics; Piperidines; Small molecules
  • Mechanism of Action Cholinergic receptor agonists; Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Constipation

Most Recent Events

  • 23 Sep 2003 Phase-II clinical trials in Constipation in USA (PO)
  • 14 Jun 2002 Phase-I clinical trials in Constipation in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top